SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000812796-09-000036
Filing Date
2009-04-16
Accepted
2009-04-16 16:41:12
Documents
3
Period of Report
2009-04-16
Effectiveness Date
2009-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A PROXY def14aproxy.htm DEF 14A 312642
2 DOR LOGO doritslogo.jpg GRAPHIC 7451
3 5 YEAR MARKET GRAPH graphmarket5.jpg GRAPHIC 77454
  Complete submission text file 0000812796-09-000036.txt   431570
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-16929 | Film No.: 09754095
SIC: 2834 Pharmaceutical Preparations